Roche Finance Europe issued EUR 1.25 bn Bonds guaranteed by Roche Holding on February 27, 2023. The transaction consists of a EUR 750 m tranche due August 2029 and a EUR 500 m tranche due February 2035. Banco Santander, Barclays Bank and Deutsche Bank acted as joint lead managers. The bonds will be listed on […]
Sika has placed bonds in a total amount of CHF 650 million, consisting of three tranches on 6 March 2023. The payment date of the new bonds is April 13, 2023 and the new bonds will be listed on SIX
Santhera Pharmaceuticals Holding announced a private placement of shares and an amendment of its existing financing with funds managed by Highbridge Capital Management to provide up to CHF 22.2 million in aggregate, subject to certain milestones
SCCF Structured Commodity & Corporate Finance , the Swiss-based trade finance expert, has issued short term tokenized notes to refinance a loan to a commodity trading firm active in biofuels. The notes were tokenized using the
Cavotec has successfully placed 12,452,830 shares at a subscription price of SEK 13.25 per share, entailing raising proceeds of approximately SEK 165 million. The subscription price was determined through an accelerated book building procedure conducted by Skandinaviska
Lenz & Staehelin has advised investment bank Jefferies as underwriter in the public offering of shares of the Lausanne based ADC Therapeutics, a commercial-stage biotechnology company helping to improve the lives of those affected by
Cavotec has successfully carried out a directed share issue, with the guidance and legal assistance of Bär & Karrer. The share placement involved 12,452,830 shares sold at a subscription price of SEK 13.25 per share, resulting
Only one year after the companthiy’s incorporation, Kellerhals Carrard has advised ETH Zurich spin-off EthonAI in its USD 6.8 million oversubscribed seed round. The round was co-led by Earlybird Venture Capital and La Famiglia with
ADC Therapeutics, a commercial-stage biotechnology company headquartered in Lausanne, announced the pricing of an underwritten offering of 12 m ADCT shares currently owned by A.T. Holdings II, an affiliate of Auven Therapeutics Holding, at a
Baker McKenzie advised PSP Swiss Property on the conversion of its CHF 1.8 billion bond portfolio to green bonds based on the company’s Green Bond Framework. The Green Bond Framework is tied to a green
